1 July 2023 false No description of principal activity Taxfiler 2024.6 8121890business:PrivateLimitedCompanyLtd2023-07-012024-06-30 81218902023-06-30 81218902023-07-012024-06-30 8121890business:AuditExempt-NoAccountantsReport2023-07-012024-06-30 8121890business:FilletedAccounts2023-07-012024-06-30 81218902024-06-30 8121890business:Director12023-07-012024-06-30 8121890business:Director22023-07-012024-06-30 8121890business:RegisteredOffice2023-07-012024-06-30 81218902023-06-30 8121890core:WithinOneYear2024-06-30 8121890core:WithinOneYear2023-06-30 8121890core:ShareCapitalcore:PreviouslyStatedAmount2024-06-30 8121890core:ShareCapitalcore:PreviouslyStatedAmount2023-06-30 8121890core:SharePremiumcore:PreviouslyStatedAmount2024-06-30 8121890core:SharePremiumcore:PreviouslyStatedAmount2023-06-30 8121890core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2024-06-30 8121890core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2023-06-30 8121890core:PreviouslyStatedAmount2024-06-30 8121890core:PreviouslyStatedAmount2023-06-30 8121890business:SmallEntities2023-07-012024-06-30 8121890countries:EnglandWales2023-07-012024-06-30 8121890core:IntangibleAssetsOtherThanGoodwill2023-06-30 8121890core:IntangibleAssetsOtherThanGoodwill2024-06-30 8121890core:PlantMachinery2023-06-30 8121890core:FurnitureFittings2023-06-30 8121890core:PlantMachinery2023-07-012024-06-30 8121890core:FurnitureFittings2023-07-012024-06-30 8121890core:PlantMachinery2024-06-30 8121890core:FurnitureFittings2024-06-30 81218902022-07-012023-06-30 iso4217:GBP xbrli:pure
Company Registration No. 8121890 (England and Wales)
CUPID PEPTIDE COMPANY LIMITED Unaudited accounts for the year ended 30 June 2024
CUPID PEPTIDE COMPANY LIMITED Unaudited accounts Contents
Page
- 2 -
CUPID PEPTIDE COMPANY LIMITED Company Information for the year ended 30 June 2024
Directors
William Ryves Andrew Speirs
Company Number
8121890 (England and Wales)
Registered Office
30 Elm Street Cardiff CF24 3QS
Accountants
STAS Ltd 253 Cowbridge Road West Cardiff CF5 5TD
- 3 -
CUPID PEPTIDE COMPANY LIMITED Statement of financial position as at 30 June 2024
2024 
2023 
Notes
£ 
£ 
Fixed assets
Intangible assets
64,485 
64,485 
Tangible assets
1,266 
355 
65,751 
64,840 
Current assets
Debtors
- 
2,550 
Cash at bank and in hand
3,274 
2,051 
3,274 
4,601 
Creditors: amounts falling due within one year
(78,211)
(63,644)
Net current liabilities
(74,937)
(59,043)
Net (liabilities)/assets
(9,186)
5,797 
Capital and reserves
Called up share capital
96,549 
96,549 
Share premium
18,572 
18,572 
Profit and loss account
(124,307)
(109,324)
Shareholders' funds
(9,186)
5,797 
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board of Directors and authorised for issue on 28 March 2025 and were signed on its behalf by
William Ryves Director Company Registration No. 8121890
- 4 -
CUPID PEPTIDE COMPANY LIMITED Notes to the Accounts for the year ended 30 June 2024
1
Statutory information
CUPID PEPTIDE COMPANY LIMITED is a private company, limited by shares, registered in England and Wales, registration number 8121890. The registered office is 30 Elm Street, Cardiff, CF24 3QS.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Other 
£ 
Cost
At 1 July 2023
64,485 
At 30 June 2024
64,485 
Amortisation
At 1 July 2023
- 
At 30 June 2024
- 
Net book value
At 30 June 2024
64,485 
At 30 June 2023
64,485 
- 5 -
CUPID PEPTIDE COMPANY LIMITED Notes to the Accounts for the year ended 30 June 2024
5
Tangible fixed assets
Plant & machinery 
Fixtures & fittings 
Total 
£ 
£ 
£ 
Cost or valuation
At cost 
At cost 
At 1 July 2023
25,438 
1,668 
27,106 
Additions
1,458 
- 
1,458 
At 30 June 2024
26,896 
1,668 
28,564 
Depreciation
At 1 July 2023
25,083 
1,668 
26,751 
Charge for the year
547 
- 
547 
At 30 June 2024
25,630 
1,668 
27,298 
Net book value
At 30 June 2024
1,266 
- 
1,266 
At 30 June 2023
355 
- 
355 
6
Debtors
2024 
2023 
£ 
£ 
Amounts falling due within one year
Trade debtors
- 
2,550 
7
Creditors: amounts falling due within one year
2024 
2023 
£ 
£ 
VAT
1,394 
1,094 
Trade creditors
425 
425 
Other creditors
3,750 
3,565 
Loans from directors
72,642 
58,560 
78,211 
63,644 
8
Average number of employees
During the year the average number of employees was 0 (2023: 0).
- 6 -